Business Standard

Thursday, December 19, 2024 | 06:22 PM ISTEN Hindi

Notification Icon
userprofile IconSearch

Sudhir Valia's Sun Pharma stake helps ARC, realty business raise debt

MFs take exposure to realty arm; guarantee by investment entity gives top rating

Sebi starts probe against Sun Pharma, to also reopen insider trading case
Premium

Jash Kriplani Mumbai
Sudhir Valia, brother-in-law of Sun Pharmaceutical Industries’ founder Dilip Shanghvi, has got a helping hand in running his own businesses due to the family’s stake in India’s largest drug maker by sales. 

At least two of Valias' entities, Suraksha Realty and Suraksha Asset Reconstruction Company (ARC), have the backing of Lakshdeep Investments and Finance, which holds Valias' stake in Sun Pharma. Taking comfort from the investment entity’s stake in the latter, mutual funds (MFs) have exposure of nearly Rs 13 billion to Suraksha Realty, which operates in the Mumbai and Thane region.

To a Business Standard query, Lakshmi Iyer, chief

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in